Tandem Diabetes Care, Inc. (TNDM)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Tandem Diabetes Care, Inc. (TNDM) is down 34.4% since the beginning of the year. At $14 per share, TNDM is trading 51.4% below its 52-week high of $30. Investors who bought $1,000 worth of TNDM shares 5 years ago would now be looking at an investment worth $150.

Tandem Diabetes Care, Inc. (TNDM) has returned -34.44% so far this year and -28.73% over the past 12 months. Over the last ten years, TNDM has returned -14.93% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.

Based on dividend-adjusted daily data since Nov 14, 2013, TNDM's average daily return is +0.03%, while the average monthly return is +0.95%. At this rate, an investment would double in approximately 6.1 years.

Historically, 49% of months were positive and 51% were negative. The best month was May 2018 with a return of +83.9%, while the worst month was Oct 2017 at -66.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, TNDM closed higher 49% of trading days. The best single day was Aug 28, 2017 with a return of +44.3%, while the worst single day was Nov 2, 2016 at -58.9%.

Tandem Diabetes Care, Inc. has an annualized alpha of -7.05%, beta of 1.16, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since November 14, 2013.

• This stock participated in 167.81% of S&P 500 Index downside but only 32.11% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TNDM ranks 26 for risk / return — below 26% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Tandem Diabetes Care, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tandem Diabetes Care, Inc. was 99.25%, occurring on Nov 3, 2017. The portfolio has not yet recovered.

The current Tandem Diabetes Care, Inc. drawdown is 95.19%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Tandem Diabetes Care, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Tandem Diabetes Care, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.